Atacand HCT

AstraZeneca sells US rights to 4 non-core drugs
Biopharma Dive
Wed, 01/3/18 - 11:07 am
AstraZeneca
ANI Pharmaceuticals
Atacand
Atacand HCT
Casodex
Arimidex